Alexander Phd Rph Kenneth S, Kaushik Sarita
College of Pharmacy, The University of Toledo, Toledo, Ohio.
Int J Pharm Compd. 2004 Mar-Apr;8(2):147-52.
Mexiletine hydrochloride is an orally active class I antiarrythmic agent. An extemporaneous solution of mexiletine hydrochloride was prepared for this study. Water was chosen as the vehicle due to the high solubility of the drug in water. Sorbitol, simple syrup and raspberry syrup were used as sweeteners in an attempt to mask the bitter taste of the drug. The solution was analyzed over 91 days of storage at five temperatures, ie, 4, 30, 40, 50 and 60 deg C.The sample was analyzed at 2, 6, 24, and 48 hours and the at 7, 14, 21, 28, 35, 42, 49, 56, 63, 70, 77, 84 and 91 days at each designated temperature. The peak area for the mexiletine hydrchloride peak at time t=0 was taken as 100%; and, accordingly the percentages of intact drug remaining at each interval were calculated. The log percentage of the drug remaining was lotted agaisnst time (in days) at each temperature. The first-order constants for mexiletine hydrochloride at 4, 30, 40, 50, and 60 deg C were calculated to be -0.0007, -0.0009, -0.0010. -0.0011 and -0.0013, respectively. The Arrhenius plot was obtained by plotting the first-order degradation constants against the reciprocal of the absolute temperatures. The first-order degradation constant for mexiletine hydrochloride at 25 deg C was found to be 9.053 x 10-4(day-1). The energy of activation for the reaction was calculated to be -8663.88 J/mole. The shelf lives of the formmulation at 4 and 25 deg C were found to be 173.3 and 115.5 days, respectively. An attempt was made to identify and characterize any degradation products using the high-performance liquid chromatographic-mass spectrometry technique, as none of the degradation products were detected by ultraviolet analysis. However, this attempt was unsuccessful due to coating of the injection port with the sample, which might be due to crystallization of any of the excipients of the formulation under high temperatures. A degradation mechanism has been hypothesized based on either acid or base attack on the parent compound. The products from this degradation are presented.
盐酸美西律是一种口服有效的Ⅰ类抗心律失常药。本研究制备了盐酸美西律的临时溶液。由于该药物在水中的高溶解度,选择水作为溶剂。使用山梨醇、单糖浆和覆盆子糖浆作为甜味剂,试图掩盖药物的苦味。该溶液在五个温度(即4、30、40、50和60℃)下储存91天进行分析。在每个指定温度下,分别在2、6、24和48小时以及7、14、21、28、35、42、49、56、63、70、77、84和91天对样品进行分析。将t = 0时盐酸美西律峰的峰面积视为100%;相应地,计算每个时间间隔剩余完整药物的百分比。在每个温度下,将剩余药物的对数百分比与时间(天)作图。计算得出盐酸美西律在4、30、40、50和60℃下的一级速率常数分别为-0.0007、-0.0009、-0.0010、-0.0011和-0.0013。通过将一级降解速率常数与绝对温度的倒数作图得到阿仑尼乌斯图。发现盐酸美西律在25℃下的一级降解速率常数为9.053×10⁻⁴(天⁻¹)。计算得出该反应的活化能为-8663.88 J/mol。发现该制剂在4℃和25℃下的保质期分别为173.3天和115.5天。尝试使用高效液相色谱-质谱技术鉴定和表征任何降解产物,因为通过紫外分析未检测到任何降解产物。然而,由于进样口被样品覆盖,该尝试未成功,这可能是由于制剂的任何辅料在高温下结晶所致。基于母体化合物受到酸或碱攻击的情况推测了一种降解机制。展示了这种降解产生的产物。